NFA
FMI

Nuveen Fund Advisors’s Foundation Medicine, Inc. FMI Stock Holding History

Nuveen Fund Advisors’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-7,660
Closed -$247K – 454
2017
Q1 		$247K Buy
+7,660
New +$191K 0.03% 389
2016
Q4 		– Sell
-9,455
Closed -$221K – 495
2016
Q3 		$221K Buy
+9,455
New +$215K 0.03% 417

Other funds holding FMI

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Nuveen Fund Advisors's FMI Position: Q2 2017 in Review

Nuveen Fund Advisors sold out of Foundation Medicine, Inc. (FMI) in Q2 2017, closing a stake of 7,660 shares — an estimated $247K sold.

Nuveen Fund Advisors first reported a position in FMI in Q3 2016 and held it in 2 quarters. The position peaked at $247K in Q1 2017. 103 funds tracked by Wall St. Rank hold FMI as of Q2 2017.

  • Nuveen Fund Advisors reported no remaining Foundation Medicine, Inc. position as of Q2 2017 after selling out during the quarter.
  • Nuveen Fund Advisors sold 7,660 Foundation Medicine, Inc. shares in Q2 2017, an estimated $247K.
  • Nuveen Fund Advisors first reported a position in Foundation Medicine, Inc. in Q3 2016 and held it in 2 quarters.
  • Nuveen Fund Advisors's Foundation Medicine, Inc. position peaked at $247K in Q1 2017.
  • 103 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q2 2017.

Based on Nuveen Fund Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.